Congenital lens malformations

Q17_CONGEN_LENS_MALFO

Endpoint definition

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

557745

1. Apply sex-specific rule

None

557745

2. Check conditions

None

557745

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 Q12
  • Cause of death: ICD-10 Q12

2 out of 7 registries used, show all original rules.

197

4. Check minimum number of events

None

197

5. Include endpoints

None

197

6. Filter based on genotype QC (FinnGen only)

178

Control definitions (FinnGen only)

Control exclude
Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q1
Name in latin
Malformationes congenitae lentis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2183 1150 1030
Only index persons 1768 928 840
Unadjusted period prevalence (%)
Whole population 0.03 0.03 0.03
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 10.95 12.13 9.56
Only index persons 18.23 19.68 16.63

-FinnGen-

Key figures

All Female Male
Number of individuals 178 111 67
Unadjusted period prevalence (%) 0.04 0.04 0.03
Median age at first event (years) 35.64 35.93 35.15

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
186
Matched controls
1860
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q12.0
ICD-10 Finland
Congenital cataract
+∞
228.1
169
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
15.6
70.5
76
79
H27.0
ICD-10 Finland
Aphakia
387.2
33.0
32
*
H26.4
ICD-10 Finland
After-cataract
9.7
30.6
40
51
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
5.4
28.7
91
282
CJB10
NOMESCO Finland
Laser discission of secondary cataract
9.5
26.0
34
43
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
5.0
24.1
71
203
S01ED51
ATC
timolol, combinations; ophthalmic
8.1
21.1
31
45
CKD60
NOMESCO Finland
Anterior vitrectomy
124.0
21.1
22
*
114
Kela drug reimbursment
Glaucoma
8.1
20.6
30
43
7433A
ICD-9 Finland
Congenital anomalies of eye, Congenital cataract and lens anomalies
+∞
19.1
18
*
ZXA00
NOMESCO Finland
Right side
4.0
17.2
67
230
74439
ICD-8 Finland
Congenital anomalies of eye, Cataracta NUD
186.0
16.8
17
*
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
52.6
16.4
19
*
H26.00
ICD-10 Finland
Infantile, juvenile and presenile cataract
+∞
15.9
15
*
S01ED01
ATC
timolol; ophthalmic
17.6
14.3
22
14
WX140
NOMESCO Finland
Parabulbar anesthesy
11.9
14.3
26
25
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
37.2
13.8
17
5
TCG10
NOMESCO Finland
Removal of sutures from cornea
+∞
13.7
13
*
XCK10
NOMESCO Finland
Photography of fundus of eye
5.1
13.4
31
70
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
139.0
12.6
13
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.4
12.2
35
94
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
32.4
11.8
15
5
CJD20
NOMESCO Finland
Extracapsular cataract extraction with implantation of artificial lens in posterior chamber
+∞
11.6
11
*
Q12.1
ICD-10 Finland
Congenital displaced lens
+∞
11.6
11
*
CJF10
NOMESCO Finland
Secondary implantation of artificial lens in posterior chamber
+∞
11.6
11
*
H53.0
ICD-10 Finland
Amblyopia ex anopsia
19.3
10.9
16
9
S01EE01
ATC
latanoprost; ophthalmic
8.6
10.8
23
30
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.2
10.7
54
212
H26.02
ICD-10 Finland
Presenil cataract
17.4
10.6
16
10
H33.0
ICD-10 Finland
Retinal detachment with retinal break
11.6
10.6
19
18
3793A
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]
116.3
10.5
11
*
Z3229
NOMESCO Finland
Other healthcare associate professional
4.2
10.5
31
85
ZXD10
NOMESCO Finland
Scheduled procedure
2.8
10.4
83
418
ZXA10
NOMESCO Finland
Bilateral
3.2
10.3
51
197
H26.01
ICD-10 Finland
Infantile, juvenile and presenile cataract
58.1
9.8
11
*
H27.1
ICD-10 Finland
Dislocation of lens
105.2
9.5
10
*
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
19.8
9.1
13
7
ZXA05
NOMESCO Finland
Left side
2.9
8.8
51
214
S01EC01
ATC
acetazolamide; systemic
13.6
8.5
14
11
S01EC03
ATC
dorzolamide; ophthalmic
+∞
8.4
8
*
S01BA04
ATC
prednisolone; ophthalmic
15.4
8.3
13
9
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
8.0
59
280
H50.1
ICD-10 Finland
Divergent concomitant strabismus
26.2
7.7
10
*
S01EA03
ATC
apraclonidine; ophthalmic
26.2
7.7
10
*
ZXD20
NOMESCO Finland
Day surgery
3.1
7.4
35
130
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
21.0
7.2
10
5
S01CA02
ATC
prednisolone and antiinfectives; ophthalmic
21.0
7.2
10
5
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
3.0
6.9
34
130
S01EA05
ATC
brimonidine; ophthalmic
11.6
6.4
11
10
S01AX11
ATC
[U] ofloxacin
6.7
6.3
15
24
37872
ICD-8 Finland
Other diseases of eye, Aphakia artefacta, acquisita
+∞
6.3
6
*
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
+∞
6.3
6
*
3619
FHL
Other operations in this group, such as corneal refractive surgery
+∞
6.3
6
*
H54.4
ICD-10 Finland
Blindness, monocular
+∞
6.3
6
*
H52.1
ICD-10 Finland
Myopia
4.0
6.3
18
48
S01EC04
ATC
brinzolamide; ophthalmic
6.4
6.1
15
25
Z2446
NOMESCO Finland
Social worker
3.4
6.1
23
74
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
7.7
6.0
13
18

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
88
621
1.79
3.71
6.8
4.8
35.92
36.86
g/l
0.68
80
597
61
385
1.87
3.70
4.2
4.7
94.16
93.76
%
0.04
61
380
46
264
1.99
3.69
2.5
2.7
2.45
2.45
mmol/l
0.21
40
237
56
356
1.82
3.27
6.2
4.1
—
—
—
0
0
95
710
1.69
3.10
13.1
7.7
1.22
1.22
mmol/l
0.68
85
614
71
492
1.72
3.06
4.5
3.3
2.37
2.37
mmol/l
0.13
66
448
34
188
1.99
3.00
2.5
4.7
20.05
7.68
umol/l
0.38
29
166
25
126
2.14
2.81
2.6
5.6
0.30
0.48
%
—
5
40
33
186
1.94
2.76
2.2
1.7
—
—
—
0
0
62
424
1.69
2.76
5.9
3.9
7.39
7.40
ph
0.40
44
303
108
858
1.62
2.61
9.9
5.3
6.48
6.39
mmol/l
0.16
103
794
110
880
1.61
2.57
9.9
7.3
1.85
1.94
e9/l
0.59
102
777
5
7
7.30
2.56
1.4
1.1
—
—
—
0
0
8
22
3.75
2.39
2.3
1.5
—
—
—
0
0
8
22
3.75
2.39
2.3
1.5
—
—
—
0
0
8
22
3.75
2.39
2.3
1.5
—
—
—
0
0
8
22
3.75
2.39
2.3
1.5
—
—
—
0
0
5
8
6.38
2.38
1.4
1.9
—
—
—
0
0
109
880
1.58
2.37
9.7
7.6
0.21
0.19
e9/l
0.66
100
762
106
853
1.56
2.32
9.1
7.4
0.59
0.55
e9/l
0.96
96
727
25
136
1.97
2.31
11.2
8.8
7.38
7.42
ph
1.24
17
68
6
13
4.73
2.29
1.3
1.2
14.27
26.93
umol/l
—
6
13
106
857
1.55
2.25
9.1
7.4
0.04
0.04
e9/l
0.01
96
729
10
35
2.96
2.24
5.9
3.3
7.40
7.41
ph
—
10
35
57
400
1.61
2.24
2.3
2.4
2.97
2.70
mg/l
0.40
52
348
25
139
1.92
2.18
10.9
8.6
0.12
1.00
mmol/l
0.47
19
117
115
956
1.53
2.08
12.8
11.0
4.47
3.95
e9/l
0.88
103
816
8
26
3.17
2.04
5.5
3.3
9.86
8.75
kpa
—
8
26
8
26
3.17
2.04
5.5
3.3
5.16
5.00
kpa
—
8
26
77
592
1.51
1.99
14.5
9.5
1.27
1.15
inr
1.06
62
486
24
136
1.88
1.99
1.2
1.3
152.40
146.11
u/ml
—
10
48
7
22
3.26
1.90
5.6
3.0
—
—
—
0
0
43
294
1.60
1.86
3.7
2.7
498.89
536.85
mosm/kgh2o
0.55
38
257
33
212
1.68
1.81
2.3
1.9
—
—
—
0
0
22
127
1.83
1.73
6.8
11.9
24.72
25.26
mmol/l
0.31
22
127
24
143
1.78
1.71
5.2
3.1
—
—
—
0
0
59
445
1.48
1.63
3.9
2.9
0.13
0.28
e6/l
1.66
43
315
32
210
1.63
1.63
2.2
2.7
30.14
29.30
s
0.37
32
205
47
341
1.51
1.56
3.8
2.7
6.27
6.26
e6/l
0.00
39
307
132
1164
1.46
1.54
8.8
7.8
87.30
81.67
u/l
0.33
127
1106
6
21
2.92
1.52
1.2
1.5
2.32
2.22
g/l
—
6
14
6
21
2.92
1.52
1.2
1.5
0.32
0.31
g/l
—
6
14
6
21
2.92
1.52
1.2
1.5
—
—
—
0
0
6
21
2.92
1.52
1.2
1.5
5.09
6.34
g/l
—
6
15
19
112
1.78
1.42
1.9
2.6
12519.83
7311.54
u/l
—
10
43
49
366
1.46
1.40
1.9
1.5
20.81
21.98
nmol/l
0.21
42
314
70
561
1.40
1.36
10.6
7.3
—
—
—
0
0
0
39
0.00
1.35
0.0
1.1
—
—
—
0
0
18
106
1.77
1.35
4.9
3.4
75.78
70.30
e9/l
0.30
13
85
19
115
1.73
1.31
3.8
7.4
23.82
24.25
mmol/l
0.37
19
115
6
25
2.45
1.25
1.2
1.8
284.33
272.59
mosm/kgh2o
—
6
17
23
149
1.62
1.24
10.7
10.1
—
—
—
0
0
5
19
2.67
1.22
3.0
12.2
13.00
12.08
%
—
5
19
5
19
2.67
1.22
1.8
1.2
—
—
—
0
0
58
458
1.39
1.22
3.1
2.7
—
—
—
0
0
38
278
1.46
1.21
2.0
1.6
—
—
—
0
0
91
773
1.35
1.20
6.2
6.9
18.73
11.10
umol/l
0.60
85
738
6
26
2.35
1.19
1.0
1.2
—
—
—
0
0
7
30
2.38
1.13
3.0
3.3
3.36
4.90
e9/l
—
7
30
52
408
1.38
1.13
5.2
5.0
—
—
—
0
0
8
41
1.99
1.10
2.8
7.1
75.03
64.14
%
—
8
41
13
75
1.79
1.06
1.2
1.1
—
—
—
0
0
14
83
1.74
1.04
2.1
3.1
23.10
7.56
ug/l
—
9
73
61
497
1.34
1.04
6.6
6.9
—
—
—
0
0
61
498
1.33
1.02
3.9
3.2
8.21
8.18
mmol/l
0.01
51
436
93
807
1.30
1.01
12.8
10.6
0.00
0.00
e9/l
0.72
75
645
169
1605
1.58
0.99
20.0
13.6
24.78
20.87
mg/l
0.72
147
1274
141
1298
1.36
0.99
4.7
4.2
14.69
14.64
pmol/l
0.08
133
1190
7
36
1.98
0.98
1.3
2.4
—
—
—
0
0
41
318
1.37
0.95
1.2
1.3
55.43
31.82
iu/ml
—
9
89
7
37
1.93
0.95
2.6
7.3
74.57
61.49
%
—
7
37
51
411
1.33
0.93
5.3
4.1
5.61
10.34
mg/mmol
0.68
36
261
175
1680
1.70
0.92
22.0
16.1
76.71
72.40
umol/l
0.69
175
1655
70
592
1.29
0.90
2.5
1.8
102.94
98.04
pmol/l
0.38
34
308
50
404
1.32
0.89
4.1
3.4
43.40
58.75
mg/l
0.23
38
266
34
260
1.38
0.86
6.1
3.9
2569.40
271.55
ng/l
0.43
27
170
149
1394
1.35
0.85
5.6
5.4
37.78
38.02
mmol/mol
0.12
141
1321
12
73
1.69
0.84
8.0
3.2
206.92
201.93
ng/l
0.02
12
67
0
25
0.00
0.79
0.0
2.2
—
586.06
—
0
16
70
603
1.26
0.76
4.8
3.9
126.37
69.79
e6/l
0.37
49
402
24
178
1.40
0.73
8.9
9.4
104.58
104.44
mmol/l
0.06
24
178
7
40
1.78
0.72
7.0
10.7
—
—
—
0
0
172
1657
1.51
0.72
16.6
11.1
—
—
—
0
0
121
1118
1.24
0.67
3.2
3.6
41.75
40.98
u/l
0.05
110
1073
5
28
1.81
0.66
8.4
2.8
6.22
7.23
pmol/l
—
5
28
7
44
1.61
0.66
3.0
3.2
58.00
60.73
%
—
7
44
24
182
1.37
0.65
1.3
1.2
—
—
—
0
0
10
63
1.62
0.63
10.1
3.3
—
—
—
0
0
0
20
0.00
0.60
0.0
1.5
—
—
—
0
0
25
194
1.33
0.60
2.0
1.6
1244.93
1241.55
nmol/l
0.01
14
152
0
22
0.00
0.59
0.0
3.6
—
7.68
—
0
22
59
512
1.22
0.59
4.7
3.2
21.76
46.68
e6/l
0.88
43
382
0
23
0.00
0.58
0.0
2.3
—
1336.06
—
0
16
22
168
1.35
0.58
1.1
1.5
—
—
—
0
0
172
1667
1.42
0.57
13.4
10.9
27.18
26.82
u/l
0.09
167
1631
46
390
1.24
0.57
2.1
1.8
—
—
—
0
0
10
65
1.57
0.56
6.4
8.9
2.05
1.21
mg/l
—
10
60
23
178
1.33
0.56
1.2
1.9
—
—
—
0
0
9
59
1.55
0.56
1.0
1.4
—
—
—
0
0
16
120
1.36
0.48
1.4
1.4
—
—
—
0
0
68
610
1.18
0.47
1.8
2.0
—
—
—
0
0
22
176
1.28
0.44
1.6
1.6
—
—
—
0
0
10
70
1.45
0.42
1.1
1.1
—
0.57
—
0
7
5
32
1.58
0.42
1.6
2.0
—
—
—
0
0
32
270
1.22
0.42
2.7
2.6
278.83
96.87
ug/g
0.42
23
201
52
461
1.18
0.41
1.4
1.6
1.84
2.25
g/l
1.20
34
265
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
17
0.00
0.41
0.0
3.1
—
1.19
—
0
17
0
17
0.00
0.41
0.0
3.1
—
105.71
—
0
17
0
17
0.00
0.41
0.0
3.1
—
3.99
—
0
17
24
197
1.25
0.40
1.3
1.2
—
—
—
0
0
9
66
1.38
0.39
2.1
2.0
—
—
—
0
0
57
512
1.16
0.38
3.4
3.6
21.56
149.06
ng/l
0.51
38
322
30
254
1.22
0.38
3.1
2.9
4.44
2.75
e6/l
0.37
13
121
20
162
1.26
0.37
7.8
6.8
7.35
7.38
ph
1.76
13
99
36
312
1.19
0.37
1.2
1.7
—
—
—
0
0
76
700
1.14
0.36
3.4
2.8
—
—
estimate
—
0
0
33
380
0.84
0.36
6.9
3.6
1.01
1.02
kg/l
1.22
25
232
23
193
1.22
0.32
1.2
1.3
—
—
—
0
0
6
47
1.29
0.32
1.0
1.2
—
—
—
0
0
29
250
1.19
0.32
1.3
1.5
240.00
444.07
titre
—
8
59
7
53
1.33
0.31
1.1
1.3
—
—
—
0
0
7
54
1.31
0.31
1.4
1.1
—
—
—
0
0
22
186
1.21
0.29
1.7
1.7
—
—
—
0
0
40
358
1.15
0.28
1.8
2.3
0.92
1.41
mg/l
0.69
26
289
46
506
0.88
0.28
1.8
1.5
0.72
1.73
u/ml
1.08
14
129
15
123
1.24
0.26
7.3
5.2
7.39
7.42
ph
1.25
15
100
9
72
1.26
0.26
1.1
1.1
1.49
1.55
g/l
—
9
72
9
72
1.26
0.26
1.1
1.1
0.91
0.87
g/l
—
9
72
14
114
1.25
0.26
1.5
1.4
—
—
—
0
0
143
1388
1.13
0.25
4.1
3.9
1.33
1.25
mmol/l
0.68
132
1305
155
1512
1.15
0.25
6.0
5.1
1.91
1.84
mu/l
0.27
149
1412
82
862
0.91
0.22
5.7
3.6
0.00
0.00
estimate
-0.00
24
204
0
11
0.00
0.21
0.0
4.7
—
1.34
—
0
11
0
11
0.00
0.21
0.0
4.0
—
2.76
—
0
11
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
13
0.00
0.21
0.0
2.8
—
0.26
—
0
6
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
6
50
1.21
0.20
1.7
1.4
—
—
—
0
0
45
485
0.90
0.20
3.5
2.6
—
0.25
—
0
8
83
869
0.92
0.19
5.7
3.6
0.00
0.00
estimate
-0.00
24
202
60
637
0.91
0.19
3.3
2.7
—
—
—
0
0
16
185
0.85
0.19
1.4
1.2
—
—
—
0
0
10
121
0.82
0.18
1.5
1.7
—
—
—
0
0
53
497
1.09
0.18
2.7
2.2
—
—
—
0
0
7
61
1.15
0.18
5.6
5.6
37.06
36.94
°c
—
7
61
5
66
0.75
0.17
2.8
2.0
—
—
—
0
0
52
489
1.09
0.16
2.6
2.4
—
—
—
0
0
62
653
0.92
0.16
2.0
1.9
1.25
1.35
mmol/l
0.63
49
560
84
874
0.93
0.16
5.7
3.7
0.00
0.02
estimate
0.50
23
195
6
76
0.78
0.16
2.0
2.1
—
—
—
0
0
10
83
1.22
0.16
1.1
1.7
—
—
—
0
0
15
171
0.87
0.15
2.6
2.6
0.77
0.71
ug/l
—
9
101
11
93
1.19
0.15
1.1
1.1
—
—
—
0
0
32
296
1.10
0.14
1.3
1.3
9.95
6.62
u/ml
0.14
11
115
10
84
1.20
0.14
3.1
6.0
0.64
0.63
%
—
10
84
10
85
1.19
0.12
1.0
1.1
—
—
—
0
0
12
136
0.87
0.11
1.8
1.7
—
—
—
0
0
152
1499
1.08
0.11
5.4
5.0
2.80
2.74
mmol/l
0.38
145
1416
146
1481
0.93
0.10
5.0
4.5
1.46
1.46
mmol/l
0.07
137
1397
144
1419
1.07
0.10
26.3
17.3
332.97
333.30
g/l
0.19
144
1414
13
145
0.89
0.10
1.8
1.6
—
—
—
0
0
50
480
1.06
0.09
6.3
3.8
0.00
0.00
estimate
-0.00
23
193
13
144
0.90
0.08
1.8
1.6
—
—
—
0
0
13
144
0.90
0.08
1.8
1.6
—
—
—
0
0
11
98
1.13
0.08
7.6
5.8
—
—
—
0
0
6
73
0.82
0.08
1.2
1.2
—
—
—
0
0
13
143
0.90
0.07
1.8
1.6
—
—
—
0
0
179
1779
1.16
0.07
29.9
20.5
30.02
30.09
pg
0.28
179
1762
179
1779
1.16
0.07
30.2
20.7
135.31
136.64
g/l
0.70
179
1761
179
1779
1.16
0.07
30.6
21.0
39.90
40.81
%
1.20
179
1760
179
1778
1.18
0.07
29.9
20.5
90.01
90.03
fl
0.02
179
1761
9
83
1.09
0.07
1.2
1.2
—
—
—
0
0
32
305
1.06
0.07
2.7
1.9
—
—
—
0
0
69
705
0.97
0.05
4.8
3.3
6.26
6.19
ph
0.25
44
379
52
506
1.04
0.05
1.6
1.6
—
—
—
0
0
17
161
1.06
0.03
1.4
1.4
—
—
—
0
0
10
92
1.09
0.03
1.0
1.1
—
—
—
0
0
147
1460
1.03
0.03
4.6
4.4
5.85
5.76
mmol/l
0.29
138
1355
11
117
0.94
0.02
12.1
4.3
7.40
7.36
ph
—
6
88
49
497
0.98
0.01
4.9
2.9
0.00
0.01
estimate
0.50
22
170
10
99
1.01
0.00
3.3
2.1
—
—
—
0
0
10
103
0.97
0.00
3.4
3.8
—
—
—
0
0
149
1487
1.01
0.00
4.9
4.5
4.66
4.63
mmol/l
0.15
141
1410
65
655
0.99
0.00
5.9
3.4
0.00
0.02
estimate
0.74
22
172
15
152
0.99
0.00
2.5
3.3
0.23
0.22
g/l
0.33
15
141
0
8
0.00
0.00
0.0
6.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
2.0
—
62.88
—
0
8
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
51.00
—
0
5
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
7
79
0.88
-0.00
2.6
1.7
—
3.63
—
0
16
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
98
0.91
-0.00
2.2
2.0
—
—
—
0
0
6
69
0.87
-0.00
5.2
2.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
11.4
—
15.89
—
0
7
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
59
1.02
-0.00
1.2
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
5
53
0.94
-0.00
1.8
1.6
431.40
227.65
pmol/l
—
5
48
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint Q17_CONGEN_LENS_MALFO and mortality.

Females

Parameter HR [95% CI] p-value
Q17_CONGEN_LENS_MALFO 1.84 [1.35, 2.5] < 0.001
Birth year 0.995 [0.99, 1.0] 0.26

During the follow-up period (1.1.1998 — 31.12.2019), 66 out of 1030 females with Q17_CONGEN_LENS_MALFO died.

Males

Parameter HR [95% CI] p-value
Q17_CONGEN_LENS_MALFO 1.74 [1.29, 2.34] < 0.001
Birth year 0.982 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 61 out of 909 males with Q17_CONGEN_LENS_MALFO died.

Mortality risk

Mortality risk for people of age

years, who have Q17_CONGEN_LENS_MALFO.

N-year risk Females Males
1 0.179% 0.298%
5 1.2% 1.783%
10 2.636% 4.544%
15 5.309% 8.245%
20 9.297% 13.429%

Relationships between endpoints

Index endpoint: Q17_CONGEN_LENS_MALFO – Congenital lens malformations

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data